Timing of Antifungal Treatment and Prognostic Factors in Talaromyces marneffei Infection: A Retrospective Analysis of HIV-Positive Cases
Mycopathologia · 2026
DOI: 10.1007/s11046-025-01042-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycopathologia, 2026. Verfasst von Dongzhen Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China. Hauptthemen laut MEDLINE: Antifungal Agents, Mycoses, Talaromyces, HIV Infections. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Second Military Medical University.
Abstract (Originalsprache)
INTRODUCTION: Talaromyces marneffei (TM) infection is an emerging global threat that increasingly affects immunocompromised individuals, including those with HIV/AIDS. This study aims to systematically analyze the clinical characteristics and treatment regimens of TM infection in HIV-positive patients, with a focus on exploring the optimal timing for antifungal therapy. DESIGN: A retrospective cross-sectional analysis was performed on 96 HIV-positive patients with TM infection from the Fourth People's Hospital of Nanning, Guangxi. The analysis included symptom manifestations, symptom combination patterns, laboratory test results, co-infection status, complications, and a comprehensive evaluation of treatment regimens, including medication types, combination strategies, and timing of administration. RESULTS: The study divided patients into three groups: rapid progression death group, stable progression death group, and survival group, to dissect the heterogeneity of the disease (the first two groups collectively constitute the Death Group, representing all deceased patients). Through statistical modeling and visual data exploration, a critical value of one month for medication timing was determined. Further multivariate analysis revealed that medication timing exceeding one month was identified as an independent risk factor for patient mortality. Renal impairment and serum albumin levels < 30 g/dL were identified as poor prognostic factors, while fever and hepatosplenomegaly were associated with a better prognosis, reflecting the body's immune response capacity. CONCLUSIONS: The conclusions of this study provide empirical evidence for early empirical treatment of TM infection, explicitly defining the critical therapeutic time window as within 1 month of symptom onset. This information is crucial for improving patient outcomes and managing TM infection in immunocompromised populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
- Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Institute of Medical Mycology, Shanghai, 200003, China.
- Guangxi AIDS Clinical Treatment Centre, The Fourth People's Hospital of Nanning, Nanning, 530013, China.
- Department of Dermatology and Venereology, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China. smmuzhang@163.com.
- Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Institute of Medical Mycology, Shanghai, 200003, China. smmuzhang@163.com.
- Department of Dermatology and Venereology, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China. panweihua9@sina.com.
Förderung
- National Natural Science Foundation of China
- Second Military Medical University
Zitieren
APA
Liu, D., Lin, Y., Yu, K., Xie, Z., Peng, Z., Zhu, X., He, H., Zhang, K., & Pan, W. (2026). Timing of Antifungal Treatment and Prognostic Factors in Talaromyces marneffei Infection: A Retrospective Analysis of HIV-Positive Cases. Mycopathologia. https://doi.org/10.1007/s11046-025-01042-5
Vancouver
Liu D, Lin Y, Yu K, Xie Z, Peng Z, Zhu X, et al. Timing of Antifungal Treatment and Prognostic Factors in Talaromyces marneffei Infection: A Retrospective Analysis of HIV-Positive Cases. Mycopathologia. 2026. doi:10.1007/s11046-025-01042-5
BibTeX
@article{Liu2026,
author = {Liu, Dongzhen and Lin, Yusong and Yu, Keyao and Xie, Zhouhua and Peng, Zhipeng and Zhu, Xinlin and He, Haiyang and Zhang, Keming and Pan, Weihua},
title = {Timing of Antifungal Treatment and Prognostic Factors in Talaromyces marneffei Infection: A Retrospective Analysis of HIV-Positive Cases},
journal = {Mycopathologia},
year = {2026},
doi = {10.1007/s11046-025-01042-5}
}
EUVIMED